Literature DB >> 21914502

Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage.

Larissa Schwarzkopf1, Petra Menn, Simone Kunz, Rolf Holle, Jörg Lauterberg, Peter Marx, Hilmar Mehlig, Sonja Wunder, Reiner Leidl, Carolin Donath, Elmar Graessel.   

Abstract

OBJECTIVE: Rising life expectancy is associated with higher prevalence rates of dementia disorders. When disease progresses the patients' call on formal health care services and on social support grows which imposes increasing costs of care. The aim of this study was to investigate the costs for patients with mild and moderate dementia in community setting in Germany.
METHODS: We assessed total costs of care and individual cost components for 383 community-living dementia patients alongside a cluster-randomized trial from societal and health insurance perspective. Utilization of formal health care services was based on insurance claims data and time dedicated to informal care was assessed within caregiver interviews. We estimated costs using a two-part regression model adjusting for age, gender and cluster-effects.
RESULTS: Costs of care equal €47,747 (Euros) from societal perspective which is almost the 4.7-fold of health insurance expenditures. Valued informal care covers 80.2% of societal costs and increases disproportionally when disease progresses. In moderate dementia the corresponding amount exceeds the one in mild dementia by 69.9%, whereas costs for formal health care services differ by 14.3%.
CONCLUSION: Due to valued informal care, costs of care for community-living patients with moderate dementia are significantly higher than for patients with mild dementia. Informal care is a non-cash item saving expenditures for professional care. To relieve social security system and family caregivers as well as to allow dementia patients to stay at home as long as possible, concepts fostering community-based dementia care and support to family caregivers need to be further developed.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21914502     DOI: 10.1016/j.jval.2011.04.005

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  27 in total

1.  [Efficacy and cost effectiveness of case management in patients with dementia].

Authors:  S Mostardt; D Matusiewicz; W Schröer; J Wasem; A Neumann
Journal:  Z Gerontol Geriatr       Date:  2012-10       Impact factor: 1.281

2.  Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries.

Authors:  Ansgar Wübker; Sandra M G Zwakhalen; David Challis; Riitta Suhonen; Staffan Karlsson; Adelaida Zabalegui; Maria Soto; Kai Saks; Dirk Sauerland
Journal:  Eur J Health Econ       Date:  2014-07-29

3.  The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic.

Authors:  Petra Marešová; Veronika Zahálková
Journal:  Neurol Sci       Date:  2016-07-28       Impact factor: 3.307

4.  Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial.

Authors:  Bernhard Michalowsky; Steffen Flessa; Tilly Eichler; Johannes Hertel; Adina Dreier; Ina Zwingmann; Diana Wucherer; Henriette Rau; Jochen René Thyrian; Wolfgang Hoffmann
Journal:  Eur J Health Econ       Date:  2017-02-03

5.  Costs of Hospitalization for Dementia in Urban China: Estimates from Two Urban Health Insurance Scheme Claims Data in Guangzhou City.

Authors:  Hui Zhang; Donglan Zhang; Yujie Yin; Chao Zhang; Yixiang Huang
Journal:  Int J Environ Res Public Health       Date:  2019-08-03       Impact factor: 3.390

6.  Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours.

Authors:  J M Haro; K Kahle-Wrobleski; G Bruno; M Belger; G Dell'Agnello; R Dodel; R W Jones; C C Reed; B Vellas; A Wimo; J M Argimon
Journal:  J Nutr Health Aging       Date:  2014-07       Impact factor: 4.075

7.  Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data.

Authors:  Larissa Schwarzkopf; Petra Menn; Reiner Leidl; Sonja Wunder; Hilmar Mehlig; Peter Marx; Elmar Graessel; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2012-06-19       Impact factor: 2.655

8.  Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation.

Authors:  Susanne Hartz; Denis Getsios; Sunning Tao; Steve Blume; Grant Maclaine
Journal:  BMC Neurol       Date:  2012-02-08       Impact factor: 2.474

9.  Longitudinal Changes in the Government-Certified Index Stage and Requisite Costs for Long-Term Care Insurance System among the Community-Dwelling Demented Elderly in Japan.

Authors:  Shunichiro Shinagawa; Shiori Nakamura; Makoto Iwamoto; Norifumi Tsuno; Masahiro Shigeta; Kazuhiko Nakayama
Journal:  Int J Alzheimers Dis       Date:  2013-02-28

10.  Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study.

Authors:  Roberto Bernabei; Paolo Maria Rossini; Luigi Di Cioccio; Daniela Gragnaniello; Emilio Luda di Cortemiglia; Mahmood Attar; Delia Colombo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.